QR-12000

N/A

Report date: 2024/11/25 20:00:28

Base Information

Drug NameQR-12000
Drug Alias NameQR-12000
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II receptor antagonistsNeprilysin inhibitors
TargetsAngiotensin II receptorNeprilysin
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesWuhan Createrna Science and Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Createrna Science and Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsEssential HypertensionHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A